Type(s) of Cancer
Liver
Liver
Study Phase
Phase 3
Study Completion Date
2015-05-21
2015-05-21
NCT01015833Uploaded 10-21-2022
Access via NCI by Request
PDS UID: nci-data-499
Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Files: NCT01015833-D1![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT01015833-D1-Data-Dictionary_2.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT01015833-D1-Dataset_1.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf